Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
Myanmar: Creating an intellectual property law that protects public health
NewsLobbying for an intellectual property law that doesn’t just serve big business, but protects public health and encourages innovation in...
Read more about Myanmar: Creating an intellectual property law that protects public health
-
The Network vs. Abbvie – the first victory in reducing cost of HIV drug
NewsThe first victory has been won – and our partner in Ukraine intends to see the case through. On 4...
Read more about The Network vs. Abbvie – the first victory in reducing cost of HIV drug
-
Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
NewsSymposium in Curitiba highlights the need for a collective fight to make medicines affordable. When governments are unreceptive, it is...
Read more about Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
-
Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
Call to action NewsAbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
Read more about Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
-
Malaysia paves the way for compulsory licensing on hepatitis C medicines
NewsHistoric decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...
Read more about Malaysia paves the way for compulsory licensing on hepatitis C medicines
-
Online access: Training course on reducing barriers to medicines in Africa
NewsMaking intellectual property issues easier to understand, to increase access to medicines – and you can apply now! An online...
Read more about Online access: Training course on reducing barriers to medicines in Africa
-
Tackling the hepatitis C epidemic in Malaysia
NewsWith new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...
Read more about Tackling the hepatitis C epidemic in Malaysia
-
An important step towards affordable TAF in Ukraine
NewsGilead adds TAF, a drug used in HIV and Hepatitis B treatment, to the Medicines Patent Pool for Ukraine. It...
Read more about An important step towards affordable TAF in Ukraine
-
IAS 2017: Closing ceremony exposes Gilead Sciences
NewsConference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science...
Read more about IAS 2017: Closing ceremony exposes Gilead Sciences
-
“We want dolutegravir for all, and we want it now.”
OpinionArticle first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to...
Read more about “We want dolutegravir for all, and we want it now.”